Literature DB >> 23543720

The Clostridium difficile cpr locus is regulated by a noncontiguous two-component system in response to type A and B lantibiotics.

Jose M Suárez1, Adrianne N Edwards, Shonna M McBride.   

Abstract

The intestinal pathogen Clostridium difficile is known to grow only within the intestines of mammals, yet little is known about how the bacterium subsists in this environment. In the intestine, C. difficile must contend with innate defenses within the host, such as cationic antimicrobial peptides (CAMPs) produced by the host and the indigenous microbiota. In this study, we investigated the mechanism of activation and regulation of the CprABC transporter system, which provides resistance to multiple CAMPs and shows homology to the immunity systems of bacterial antimicrobial peptide producers. The CprABC system proved to be controlled by a noncontiguous two-component system consisting of the CprK sensor kinase and an orphan response regulator (CD3320; CprR). The CprK-CprR regulators were shown to activate cprABCK transcription in a manner similar to that by lantibiotic regulatory systems. Unlike lantibiotic producer regulation, regulation by CprK-CprR was activated by multiple lantibiotics produced by diverse Gram-positive bacteria. We identified a motif within these lantibiotics that is likely required for activation of cpr. Based on the similarities between the Cpr system and lantibiotic systems, we propose that the CprABC transporter and its regulators are relatives of lantibiotic systems that evolved to recognize multiple substrates to defend against toxins made by the intestinal microbiota.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23543720      PMCID: PMC3676062          DOI: 10.1128/JB.00166-13

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  61 in total

1.  Integration of metabolism and virulence by Clostridium difficile CodY.

Authors:  Sean S Dineen; Shonna M McBride; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2010-08-13       Impact factor: 3.490

2.  Contributions of protein structure and gene position to the compartmentalization of the regulatory proteins sigma(E) and SpoIIE in sporulating Bacillus subtilis.

Authors:  Shonna M McBride; Aileen Rubio; Lei Wang; William G Haldenwang
Journal:  Mol Microbiol       Date:  2005-07       Impact factor: 3.501

3.  Structure determination of an immunopotentiator peptide, cinnamycin, complexed with lysophosphatidylethanolamine by 1H-NMR1.

Authors:  K Hosoda; M Ohya; T Kohno; T Maeda; S Endo; K Wakamatsu
Journal:  J Biochem       Date:  1996-02       Impact factor: 3.387

4.  Regulated transcription of Clostridium difficile toxin genes.

Authors:  B Dupuy; A L Sonenshein
Journal:  Mol Microbiol       Date:  1998-01       Impact factor: 3.501

5.  Efficacy, heat stability and safety of intranasally administered Bacillus subtilis spore or vegetative cell vaccines expressing tetanus toxin fragment C.

Authors:  Sangun Lee; Boris R Belitsky; David W Brown; James P Brinker; Kathryn O Kerstein; John E Herrmann; Gerald T Keusch; Abraham L Sonenshein; Saul Tzipori
Journal:  Vaccine       Date:  2010-08-13       Impact factor: 3.641

6.  Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains.

Authors:  Frédéric Barbut; Dominique Decré; Valérie Lalande; Béatrice Burghoffer; Latifa Noussair; Anne Gigandon; Florence Espinasse; Laurent Raskine; Jérome Robert; Alain Mangeol; Catherine Branger; Jean-Claude Petit
Journal:  J Med Microbiol       Date:  2005-02       Impact factor: 2.472

7.  Genetic manipulation of Clostridium difficile.

Authors:  Laurent Bouillaut; Shonna M McBride; Joseph A Sorg
Journal:  Curr Protoc Microbiol       Date:  2011-02

8.  The tetracyclic lantibiotic actagardine. 1H-NMR and 13C-NMR assignments and revised primary structure.

Authors:  N Zimmermann; J W Metzger; G Jung
Journal:  Eur J Biochem       Date:  1995-03-15

9.  Cyclic diguanylate inversely regulates motility and aggregation in Clostridium difficile.

Authors:  Erin B Purcell; Robert W McKee; Shonna M McBride; Christopher M Waters; Rita Tamayo
Journal:  J Bacteriol       Date:  2012-04-20       Impact factor: 3.490

10.  Sublancin is not a lantibiotic but an S-linked glycopeptide.

Authors:  Trent J Oman; John M Boettcher; Huan Wang; Xenia N Okalibe; Wilfred A van der Donk
Journal:  Nat Chem Biol       Date:  2011-01-02       Impact factor: 15.040

View more
  40 in total

1.  Overexpression, purification and crystallization of the response regulator NsrR involved in nisin resistance.

Authors:  Sakshi Khosa; Astrid Hoeppner; Diana Kleinschrodt; Sander H J Smits
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-09-23       Impact factor: 1.056

Review 2.  A tale of two machines: a review of the BLAST meeting, Tucson, AZ, 20-24 January 2013.

Authors:  Christine Josenhans; Kirsten Jung; Christopher V Rao; Alan J Wolfe
Journal:  Mol Microbiol       Date:  2013-10-31       Impact factor: 3.501

3.  A novel regulator controls Clostridium difficile sporulation, motility and toxin production.

Authors:  Adrianne N Edwards; Rita Tamayo; Shonna M McBride
Journal:  Mol Microbiol       Date:  2016-03-22       Impact factor: 3.501

Review 4.  Regulation of antimicrobial resistance by extracytoplasmic function (ECF) sigma factors.

Authors:  Emily C Woods; Shonna M McBride
Journal:  Microbes Infect       Date:  2017-01-30       Impact factor: 2.700

5.  Conserved oligopeptide permeases modulate sporulation initiation in Clostridium difficile.

Authors:  Adrianne N Edwards; Kathryn L Nawrocki; Shonna M McBride
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

Review 6.  Lantibiotic resistance.

Authors:  Lorraine A Draper; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Microbiol Mol Biol Rev       Date:  2015-06       Impact factor: 11.056

7.  Examination of the Clostridioides (Clostridium) difficile VanZ ortholog, CD1240.

Authors:  Emily C Woods; Daniela Wetzel; Monjori Mukerjee; Shonna M McBride
Journal:  Anaerobe       Date:  2018-06-22       Impact factor: 3.331

8.  Effects of surotomycin on Clostridium difficile viability and toxin production in vitro.

Authors:  Laurent Bouillaut; Shonna McBride; Joseph A Sorg; Diane J Schmidt; José M Suarez; Saul Tzipori; Carmela Mascio; Laurent Chesnel; A L Sonenshein
Journal:  Antimicrob Agents Chemother       Date:  2015-05-04       Impact factor: 5.191

9.  The Clostridium difficile Dlt Pathway Is Controlled by the Extracytoplasmic Function Sigma Factor σV in Response to Lysozyme.

Authors:  Emily C Woods; Kathryn L Nawrocki; Jose M Suárez; Shonna M McBride
Journal:  Infect Immun       Date:  2016-05-24       Impact factor: 3.441

Review 10.  Bacterial Evasion of Host Antimicrobial Peptide Defenses.

Authors:  Jason N Cole; Victor Nizet
Journal:  Microbiol Spectr       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.